518 related articles for article (PubMed ID: 28801527)
1. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
3. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
Tian C; Li L; Liu T; Qu X; Qiu Y
Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers to detect membranous nephropathy in Chinese patients.
Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N
Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
7. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
11. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
12. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study.
Fouad MA; Mahedy AW; Mansour AE; Fouad NA
Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972
[TBL] [Abstract][Full Text] [Related]
13. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
[TBL] [Abstract][Full Text] [Related]
14. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
[TBL] [Abstract][Full Text] [Related]
15. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy.
Wanderley DC; Jones BD; Barbosa FAM; Araujo SA
J Bras Nefrol; 2019 Oct; 42(2):254-258. PubMed ID: 31663595
[TBL] [Abstract][Full Text] [Related]
16. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
Larsen CP; Cossey LN; Beck LH
Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
[TBL] [Abstract][Full Text] [Related]
17. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
18. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.
Hoxha E; Harendza S; Pinnschmidt HO; Tomas NM; Helmchen U; Panzer U; Stahl RA
Nephrol Dial Transplant; 2015 Nov; 30(11):1862-9. PubMed ID: 26142398
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
